Related Experiment Videos
Prognostic factors in salvage therapy of ovarian cancer
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Apical hypertrophic cardiomyopathy: A case series at a Brazilian referral center with a maximal follow-up of 15 years.
Annales de cardiologie et d'angeiologie·2021
Platinum-Gemcitabine-Avastin (PGA) for platinum-resistant/refractory ovarian cancer.
European journal of gynaecological oncology·2018
Intravenous vitamin C in the supportive care of cancer patients: a review and rational approach.
Current oncology (Toronto, Ont.)·2018
Surgical intervention in relapsed ovarian cancer is beneficial: contra.
Annals of oncology : official journal of the European Society for Medical Oncology·2013
The use of bevacizumab in the management of ovarian cancer: an argument for single-agent rather than combination therapy.
Annals of oncology : official journal of the European Society for Medical Oncology·2011
Sofetabart mipitecan, an antibody drug conjugate targeting folate receptor alpha, in high grade ovarian cancer: Results from the first-in-human phase 1 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Efficacy of Cryotherapy in Preventing Taxane-Induced Neuropathy: The CryoPac Randomised Controlled Trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Final results and predictive biomarkers of response and long-term outcomes with first-line pembrolizumab monotherapy in advanced renal cell carcinoma in the phase II KEYNOTE-427 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Navigating uncertainties and evidence gaps in adjuvant therapy for premenopausal women with HR+/HER2- breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Safety and antitumor activity of the first-in-class EGFR-HER3 bispecific antibody-drug conjugate iza-bren (BL-B01D1) in patients with pretreated locally advanced or metastatic breast cancer: a phase Ib study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Adjuvant pembrolizumab for the treatment of clear cell renal cell carcinoma: five-year results from the phase III KEYNOTE-564 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026